Epilepsies, Myoclonic
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes4
- Epilepsies, Myoclonic2
- Epilepsies, Partial1
- Epilepsy, Absence1
- Induced Pluripotent Stem Cells1
Leading journals2
- Epilepsia1
- Stem cell reports1
Leading researchers8
- Auvin S1
- Ciptasari U1
- Cross HJ1
- Doorn N1
- Frega M1
- Guerreiro M1
- Gwer S1
- Hirsch E1
Affiliations (unnormalised)6
- Academic Center for Epileptology Kempenhaeghe1
- Aga Khan University1
- Albert Einstein College of Medicine and Montefiore Medical Center1
- Austin Health and Royal Children's Hospital1
- Bambino Gesù Children's Hospital1
- Department of Clinical Neurophysiology1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.